Incidence, prevalence, and clearance of type-specific human papillomavirus infections: The young women's health study

被引:214
作者
Giuliano, AR
Harris, R
Sedjo, RL
Baldwin, S
Roe, D
Papenfuss, MR
Abrahamsen, M
Inserra, P
Olvera, S
Hatch, K
机构
[1] Univ Arizona, Arizona Canc Ctr, Tucson, AZ 85724 USA
[2] Univ Arizona, Arizona Coll Publ Hlth, Tucson, AZ 85724 USA
[3] Univ Arizona, Dept Obstet & Gynecol, Tucson, AZ 85724 USA
关键词
D O I
10.1086/341782
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
The natural history of type-specific human papillomavirus (HPV) infections was examined in a cohort of 331 women aged 18-35 years who self-referred for routine gynecological care. Participants underwent a gynecological examination at baseline and at similar-to4 and similar-to10 months after baseline. Cervical samples were collected for HPV testing and genotyping at each visit, as was information on reproductive, sexual, and medical histories. The rate of new HPV infections was 2.9% per month; the highest rates were observed for HPV types 16, 39, 84, and 51. Among women who tested negative for HPV at baseline, the cumulative probability of acquiring an oncogenic HPV strain during a 12-month follow-up period was 0.32, compared with 0.18 for nononcogenic strains. Women who had had greater than or equal to1 new male sex partner in the recent past were significantly more likely to acquire a new HPV infection (relative hazard, 2.39; 95% confidence interval, 1.20-4.76). The median time to clearance of infection was significantly longer for oncogenic strains (9.8 months) than for nononcogenic strains (4.3 months).
引用
收藏
页码:462 / 469
页数:8
相关论文
共 31 条
  • [1] PREVALENCE OF HUMAN PAPILLOMAVIRUS IN CERVICAL-CANCER - A WORLDWIDE PERSPECTIVE
    BOSCH, FX
    MANOS, MM
    MUNOZ, N
    SHERMAN, M
    JANSEN, AM
    PETO, J
    SCHIFFMAN, MH
    MORENO, V
    KURMAN, R
    SHAH, KV
    ALIHONOU, E
    BAYO, S
    MOKHTAR, HC
    CHICAREON, S
    DAUDT, A
    DELOSRIOS, E
    GHADIRIAN, P
    KITINYA, JN
    KOULIBALY, M
    NGELANGEL, C
    TINTORE, LMP
    RIOSDALENZ, JL
    SARJADI
    SCHNEIDER, A
    TAFUR, L
    TEYSSIE, AR
    ROLON, PA
    TORROELLA, M
    TAPIA, AV
    WABINGA, HR
    ZATONSKI, W
    SYLLA, B
    VIZCAINO, P
    MAGNIN, D
    KALDOR, J
    GREER, C
    WHEELER, C
    [J]. JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 1995, 87 (11): : 796 - 802
  • [2] Determinants of persistent detection of human papillomavirus DNA in the uterine cervix
    Brisson, J
    Bairati, I
    Morin, C
    Fortier, M
    Bouchard, C
    Christen, A
    Bernard, P
    Roy, M
    Meisels, A
    [J]. JOURNAL OF INFECTIOUS DISEASES, 1996, 173 (04) : 794 - 799
  • [3] Daling JR, 1996, CANCER EPIDEM BIOMAR, V5, P541
  • [4] HUMAN PAPILLOMAVIRUS INFECTION IS TRANSIENT IN YOUNG-WOMEN - A POPULATION-BASED COHORT STUDY
    EVANDER, M
    EDLUND, K
    GUSTAFSSON, A
    JONSSON, M
    KARLSSON, R
    RYLANDER, E
    WADELL, G
    [J]. JOURNAL OF INFECTIOUS DISEASES, 1995, 171 (04) : 1026 - 1030
  • [5] Epidemiology of acquisition and clearance of cervical human papillomavirus infection in women from a high-risk area for cervical cancer
    Franco, EL
    Villa, LL
    Sobrinho, JP
    Prado, JM
    Rousseau, MC
    Désy, M
    Rohan, TE
    [J]. JOURNAL OF INFECTIOUS DISEASES, 1999, 180 (05) : 1415 - 1423
  • [6] The role of nutrients in the prevention of cervical dysplasia and cancer
    Giuliano, AR
    [J]. NUTRITION, 2000, 16 (7-8) : 570 - +
  • [7] Giuliano AR, 1997, CANCER EPIDEM BIOMAR, V6, P917
  • [8] Genotyping of 27 human papillomavirus types by using L1 consensus PCR products by a single-hybridization, reverse line blot detection method
    Gravitt, PE
    Peyton, CL
    Apple, RJ
    Wheeler, CM
    [J]. JOURNAL OF CLINICAL MICROBIOLOGY, 1998, 36 (10) : 3020 - 3027
  • [9] Gravitt PE, 2000, J CLIN MICROBIOL, V38, P357
  • [10] Safety and immunogenicity trial in adult volunteers of a human papillomavirus 16 L1 virus-like particle vaccine
    Harro, CD
    Pang, YYS
    Roden, RBS
    Hildesheim, A
    Wang, ZH
    Reynolds, MJ
    Mast, TC
    Robinson, R
    Murphy, BR
    Karron, RA
    Dillner, J
    Schiller, JT
    Lowy, DR
    [J]. JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 2001, 93 (04): : 284 - 292